134 related articles for article (PubMed ID: 15233863)
1. Effect of acyl chains of phosphatidylcholines on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with phosphatidylcholines and soybean oil in rats.
Ueda K; Fujimoto M; Noto H; Sakaeda T; Iwakawa S
J Pharm Pharmacol; 2004 Jul; 56(7):855-9. PubMed ID: 15233863
[TBL] [Abstract][Full Text] [Related]
2. Prolonged circulation of menatetrenone by emulsions with hydrogenated castor oils in rats.
Ueda K; Furukawa T; Kawaguchi Y; Miki Y; Sakaeda T; Iwakawa S
J Control Release; 2004 Feb; 95(1):93-100. PubMed ID: 15013236
[TBL] [Abstract][Full Text] [Related]
3. Effect of oxyethylene moiety in polyoxyethylene sorbitan esters on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with polyoxyethylene sorbitan esters and soybean oil in rats.
Ueda K; Fujimoto M; Noto H; Kawaguchi Y; Sakaeda T; Iwakawa S
J Pharm Pharmacol; 2002 Oct; 54(10):1357-63. PubMed ID: 12396297
[TBL] [Abstract][Full Text] [Related]
4. Effect of oxyethylene numbers on the pharmacokinetics of menatetrenone incorporated in oil-in-water lipid emulsions prepared with polyoxyethylene-polyoxypropylene block copolymers and soybean oil in rats.
Ueda K; Kawaguchi Y; Iwakawa S
Biol Pharm Bull; 2008 Dec; 31(12):2283-7. PubMed ID: 19043214
[TBL] [Abstract][Full Text] [Related]
5. Effect of oxyethylene moieties in hydrogenated castor oil on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with hydrogenated castor oil and soybean oil in rats.
Ueda K; Yamazaki Y; Noto H; Teshima Y; Yamashita C; Sakaeda T; Iwakawa S
J Drug Target; 2003 Jan; 11(1):37-43. PubMed ID: 12852439
[TBL] [Abstract][Full Text] [Related]
6. Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions.
Sakaeda T; Hirano K
J Drug Target; 1998; 6(4):273-84. PubMed ID: 9894695
[TBL] [Abstract][Full Text] [Related]
7. Effect of injection volume on the pharmacokinetics of oil particles and incorporated menatetrenone after intravenous injection as O/W lipid emulsions in rats.
Ueda K; Ishida M; Inoue T; Fujimoto M; Kawahara Y; Sakaeda T; Iwakawa S
J Drug Target; 2001; 9(5):353-60. PubMed ID: 11770705
[TBL] [Abstract][Full Text] [Related]
8. O/W lipid emulsions for parenteral drug delivery. IV. Changes in the pharmacokinetics and pharmacodynamics of a highly lipophilic drug, menatetrenone.
Sakaeda T; Kakushi H; Shike T; Takano K; Harauchi T; Hirata M; Hirano K
J Drug Target; 1998; 6(3):183-9. PubMed ID: 9888304
[TBL] [Abstract][Full Text] [Related]
9. Effect of particle size on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with hydrogenated castor oils and soybean oil in rats.
Ueda K; Yamazaki Y; Teshima Y; Yamashita C; Sakaeda T; Iwakawa S
J Drug Target; 2003 May; 11(4):241-6. PubMed ID: 14578112
[TBL] [Abstract][Full Text] [Related]
10. Properties of various phospholipid mixtures as emulsifiers or dispersing agents in nanoparticle drug carrier preparations.
Ishii F; Nii T
Colloids Surf B Biointerfaces; 2005 Apr; 41(4):257-62. PubMed ID: 15748821
[TBL] [Abstract][Full Text] [Related]
11. Effect of oil-in-water lipid emulsions prepared with fish oil or soybean oil on the growth of MCF-7 cells and HepG2 cells.
Ueda K; Asai Y; Yoshimura Y; Iwakawa S
J Pharm Pharmacol; 2008 Aug; 60(8):1069-75. PubMed ID: 18644199
[TBL] [Abstract][Full Text] [Related]
12. Properties of various phosphatidylcholines as emulsifiers or dispersing agents in microparticle preparations for drug carriers.
Nii T; Ishii F
Colloids Surf B Biointerfaces; 2004 Nov; 39(1-2):57-63. PubMed ID: 15542341
[TBL] [Abstract][Full Text] [Related]
13. O/W lipid emulsions for parenteral drug delivery. III. Lipophilicity necessary for incorporation in oil particles even after intravenous injection.
Sakaeda T; Hirano K
J Drug Target; 1998; 6(2):119-27. PubMed ID: 9886236
[TBL] [Abstract][Full Text] [Related]
14. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection].
Tian LL; Tang X; He HB; Wang J
Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242
[TBL] [Abstract][Full Text] [Related]
15. Lipid microspheres for drug delivery from the pharmaceutical viewpoint.
Yamaguchi T; Mizushima Y
Crit Rev Ther Drug Carrier Syst; 1994; 11(4):215-29. PubMed ID: 7664347
[TBL] [Abstract][Full Text] [Related]
16. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment.
Justo OR; Moraes AM
J Pharm Pharmacol; 2005 Jan; 57(1):23-30. PubMed ID: 15638989
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of the emulsifying properties of phosphatidylcholine after enzymatic acyl modification.
Vikbjerg AF; Rusig JY; Jonsson G; Mu H; Xu X
J Agric Food Chem; 2006 May; 54(9):3310-6. PubMed ID: 16637690
[TBL] [Abstract][Full Text] [Related]
18. A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting.
Seki J; Sonoke S; Saheki A; Fukui H; Sasaki H; Mayumi T
Int J Pharm; 2004 Apr; 273(1-2):75-83. PubMed ID: 15010132
[TBL] [Abstract][Full Text] [Related]
19. O/W lipid emulsions for parenteral drug delivery. I. Pharmacokinetics of the oil particles and incorporated sudan II.
Sakaeda T; Takahashi K; Nishihara Y; Hirano K
Biol Pharm Bull; 1994 Nov; 17(11):1490-5. PubMed ID: 7703970
[TBL] [Abstract][Full Text] [Related]
20. Species variation in pharmacokinetics and opsonization of palmitoyl rhizoxin (RS-1541) incorporated in lipid emulsions.
Kurihara A; Shibayama Y; Kasuya A; Ikeda M; Hisaoka M
J Drug Target; 1998; 5(6):491-505. PubMed ID: 9783680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
